TABLE 2.
Characteristics of included studies for M. tuberculosis detection, grouped alphabetically by index test type
| Author, year | Country (income category) | Study design | Laboratory setting | Population | Number tested | Direct or indirect | Smear status | Condition of specimen | Processed per manufacturer's instructions | Culture reference standard |
| Hain Genotype MTBDRplus V1 | ||||||||||
| Dorman [41] | South Africa (B) | Cross-sectional | Regional | Prior screened | 223 | Direct | Both | Fresh | Yes | Liquid: MGIT 960 |
| Felkel [47] | Nigeria (B) | Cross-sectional | Regional | Known MDR-TB | 110 | Direct | Unclear | Frozen | Yes | Liquid: MGIT 960 |
| Friedrich [49] | South Africa (B) | Cross-sectional | Regional | Prior screened | 126 | Direct | Both | Fresh | Yes | Liquid: MGIT 960 |
| Luetkemeyer [64] | Multiple (B) | Cross-sectional | Regional | HIV positives | 595 | Direct | Both | Fresh | Yes | Liquid: MGIT 960 |
| Scott [84] | South Africa (B) | Cross-sectional | Unknown | All-comers | 177 | Direct | Both | Frozen | Yes | Liquid: MGIT 960 |
| Hain Genotype MTBDRplus V2 | ||||||||||
| Crudu [15] | Moldova (B) | Cross-sectional | National reference | All-comers | 336 | Direct | Both | Fresh | Yes–GenoLyse and GeneXtract | Liquid: MGIT 960 |
MDR-TB: multidrug-resistant tuberculosis.